Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-24 @ 1:06 PM
Ignite Modification Date: 2025-12-25 @ 12:21 PM
NCT ID: NCT00517361
Description: None
Frequency Threshold: 1
Time Frame: None
Study: NCT00517361
Study Brief: Phase II Study of Carboplatin and Bevacizumab (Avastin) for ER Neg, PR Neg, and HER2/Neu Neg Metastatic Breast Cancer
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Carboplatin + Avastin Carboplatin in 250mL saline IV over 30 minutes and Avastin (Bevacizumab) 15mg/kg in 100mL saline IV over 60 - 90 minutes None None 1 11 9 11 View
Serious Events(If Any):

Serious Events

Term Type Organ System Vocab View
nausea None General disorders MedDRA (Unspecified) View
pain None General disorders MedDRA (Unspecified) View
severe weakness None Nervous system disorders MedDRA (Unspecified) View
Vomiting None Gastrointestinal disorders MedDRA (Unspecified) View
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Leukopenia None Blood and lymphatic system disorders MedDRA (Unspecified) View
Constipation None Gastrointestinal disorders MedDRA (Unspecified) View
nausea None Gastrointestinal disorders MedDRA (Unspecified) View
Vomiting None Gastrointestinal disorders MedDRA (Unspecified) View
Chest pain None General disorders MedDRA (Unspecified) View
Fatigue None General disorders MedDRA (Unspecified) View
pain None General disorders MedDRA (Unspecified) View
Alanine aminotransferase increased None Investigations MedDRA (Unspecified) View
Alkaline phosphatase increased None Investigations MedDRA (Unspecified) View
Aspartate aminotransferase increased None Investigations MedDRA (Unspecified) View
Creatinine increased None Investigations MedDRA (Unspecified) View
Ear, nose and throat examination abnormal None Investigations MedDRA (Unspecified) View
Hemoglobin None Investigations MedDRA (Unspecified) View
Hemoglobin decreased None Investigations MedDRA (Unspecified) View
Hyperglycemia None Investigations MedDRA (Unspecified) View
Laboratory test abnormal None Investigations MedDRA (Unspecified) View
Leukocytes None Investigations MedDRA (Unspecified) View
Neutrophil count decreased None Investigations MedDRA (Unspecified) View
Neutrophils None Investigations MedDRA (Unspecified) View
Platelet count decreased None Investigations MedDRA (Unspecified) View
Platelets None Investigations MedDRA (Unspecified) View
Weight loss None Investigations MedDRA (Unspecified) View
Anorexia None Metabolism and nutrition disorders MedDRA (Unspecified) View
Dehydration None Metabolism and nutrition disorders MedDRA (Unspecified) View
Headache None Nervous system disorders MedDRA (Unspecified) View
Peripheral sensory neuropathy None Nervous system disorders MedDRA (Unspecified) View
Depression None Psychiatric disorders MedDRA (Unspecified) View
Insomnia None Psychiatric disorders MedDRA (Unspecified) View
Proteinuria None Renal and urinary disorders MedDRA (Unspecified) View
Breast pain None Reproductive system and breast disorders MedDRA (Unspecified) View
Bronchopulmonary hemorrhage None Respiratory, thoracic and mediastinal disorders MedDRA (Unspecified) View
Hemorrhage nasal None Respiratory, thoracic and mediastinal disorders MedDRA (Unspecified) View
Pruritus None Skin and subcutaneous tissue disorders MedDRA (Unspecified) View
Hemorrhage - Other (Specify) None Vascular disorders MedDRA (Unspecified) View
Hypertension None Vascular disorders MedDRA (Unspecified) View
Vascular - Other (Specify) None Vascular disorders MedDRA (Unspecified) View